← Leaderboards
Samikshan Dutta
University Of Nebraska Medical Center
$364,857
Attributed
$364,857
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199K · FY2019–20$200K$150K$100K$50K$0
'19
'20
Funding mix
By agency
NIH$364,857 · 1
By mechanism
R21$364,857 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Paul Trippier$6,285,040
- Ming-Fong Lin$3,077,064
- Grinu Mathew$2,591,510
- Armen Petrosyan$2,260,101
- Yaping Tu$5,176,736
Others in their field
Other Emerging Leaders on “Abiraterone”
- Li Jia · Brigham And Women'S Hospital$4,130,520
- Andrew J Armstrong · Duke University$3,558,683
- William Nathaniel Brennen · Johns Hopkins University$3,292,142
- Boyang Wu · Washington State University$2,425,417
- Himisha Beltran · Dana-Farber Cancer Inst$1,760,292
- Felix Yi-Chung Feng · University Of California, San Francisco$1,406,893
Research focus
AbirateroneAdvanced DevelopmentAcetatesAffectAndrogen Deprivation TherapyAndrogen ReceptorAndrogensAntiandrogen TherapyBindingCancer PatientCastration Resistant Prostate CancerCell NucleusCellsCell Surface ProteinsCellular TargetingCessation Of LifeChip-SeqChromatinChromosomal LocationChromosomesClinically SignificantClinical TrialsComplexDeprivation
Grant awards (2)
Androgen Receptor-containing novel transcriptional complex for cancer-specific gene expression in therapy-resistant Prostate Cancer$199,013
R21 · FY2020 · CA · contact PI
Androgen Receptor-containing novel transcriptional complex for cancer-specific gene expression in therapy-resistant Prostate Cancer$165,844
R21 · FY2019 · CA · contact PI